MYRIAD GENETICS, INC. Deferred Tax Liabilities, Tax Deferred Income
MYRIAD GENETICS, INC. (MYGN) had Deferred Tax Liabilities, Tax Deferred Income of $0 as of 2020-12-31, per its 10-KT filed 2021-03-16.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome · last filed 2021-03-16
- 2020-12-31: Deferred Tax Liabilities, Tax Deferred Income $0.00.
- 2020-06-30: Deferred Tax Liabilities, Tax Deferred Income $0.00.
- 2019-06-30: Deferred Tax Liabilities, Tax Deferred Income $7.70M.
| Period end | Deferred Tax Liabilities, Tax Deferred Income |
|---|---|
| 2020-12-31 | $0.00 10-KT · filed 2021-03-16 |
| 2020-06-30 | $0.00 10-KT · filed 2021-03-16 |
| 2019-06-30 | $7.70M 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |